229
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Annual Direct Economic Burden and Influencing Factors of Dry Eye Diseases in Central China

, , , , , & show all
Pages 121-128 | Received 01 Feb 2021, Accepted 19 Jul 2021, Published online: 02 Aug 2021

References

  • Craig JP, Nichols KK, Akpek EK. et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.008.
  • Stapleton F, Alves M, Bunya VY. et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334–365. doi:10.1016/j.jtos.2017.05.003.
  • Guo B, Lu P, Chen X, Zhang W, Chen R. Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol. 2010;17:234–241. doi:10.3109/09286586.2010.498659.
  • Tian YJ, Liu Y, Zou HD, et al. Epidemiologic study of dry eye in populations equal or over 20 years old in Jiangning district of Shanghai. Zhonghua Yan Ke Za Zhi. 2009;45:486–491.
  • Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond). 2009;23:688–693. doi:10.1038/sj.eye.6703101.
  • Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, Kim KW. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011;129:633–638. doi:10.1001/archophthalmol.2011.78.
  • Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16:15–21. doi:10.1080/09286580802228509.
  • Paulsen AJ, Cruickshanks KJ, Fischer ME. et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799–806. doi:10.1016/j.ajo.2013.12.023.
  • Song P, Xia W, Wang M. et al. Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis. J Glob Health. 2018;8:020503. doi:10.7189/jogh.08.020503.
  • Na KS, Han K, Park YG, Na C, Joo CK. Depression, stress, quality of life, and dry eye disease in Korean women: a population-based study. Cornea. 2015;34:733–738. doi:10.1097/ICO.0000000000000464.
  • Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53:5722–5727. doi:10.1167/iovs.11-9094.
  • Le Q, Ge L, Li M. et al. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome. Acta Ophthalmol. 2014;92:e124–32. doi:10.1111/aos.12204.
  • Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. Sci Rep. 2016;6:22480. doi:10.1038/srep22480.
  • Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology. 2012;119:1811–1818. doi:10.1016/j.ophtha.2012.03.004.
  • Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415. doi:10.1016/j.ajo.2006.11.060.
  • Liang CY, Cheang WM, Wang CY. et al. The association of dry eye syndrome and psychiatric disorders: a nationwide population-based cohort study. BMC Ophthalmol. 2020;20:123. doi:10.1186/s12886-020-01395-z.
  • Wan KH, Chen LJ, Young AL. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond). 2016;30:1558–1567. doi:10.1038/eye.2016.186.
  • Bradley JL, Ozer Stillman I, Pivneva I, Guerin A, Evans AM, Dana R. Dry eye disease ranking among common reasons for seeking eye care in a large US claims database. Clin Ophthalmol. 2019;13:225–232. doi:10.2147/OPTH.S188314.
  • Clegg JP, Guest JF, Lehman A, Smith AF. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol. 2006;13:263–274. doi:10.1080/09286580600801044.
  • Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30:379–387. doi:10.1097/ICO.0b013e3181f7f363.
  • Waduthantri S, Yong SS, Tan CH. et al. Cost of dry eye treatment in an Asian clinic setting. PLoS One. 2012;7:e37711. doi:10.1371/journal.pone.0037711.
  • Mizuno Y, Yamada M, Shigeyasu C. Annual direct cost of dry eye in Japan. Clin Ophthalmol. 2012;6:755–760. doi:10.2147/OPTH.S30625.
  • Castro MC, Wilson ME, Bloom DE. Disease and economic burdens of dengue. Lancet Infect Dis. 2017;17:e70–8. doi:10.1016/S1473-3099(16)30545-X.
  • McDonald M, Patel DA, Keith MS, Snedecor JS. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf. 2016;14:144–167. doi:10.1016/j.jtos.2015.11.002.
  • Kojima T, Dogru M, Kawashima M, Nakamura S, Tsubota K. Advances in the diagnosis and treatment of dry eye [published online ahead of print Jan 29, 2020]. Prog Retin Eye Res. 78:100842. PMID: 32004729. 2020 Jan 29. doi:10.1016/j.preteyeres.2020.100842.
  • Wolffsohn JS, Arita R, Chalmers R. et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–574. doi:10.1016/j.jtos.2017.05.001.
  • Tomlinson A, Bron AJ, Korb DR. et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–2049. doi:10.1167/iovs.10-6997f.
  • Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol. 2015;26:314–318. doi:10.1097/ICU.0000000000000166.
  • Kaido M, Ibrahim OM, Kawashima M, Ishida R, Sato EA, Tsubota K. Eyelid cleansing with ointment for obstructive meibomian gland dysfunction. Jpn J Ophthalmol. 2017;61:124–130. doi:10.1007/s10384-016-0477-6.
  • Rong B, Tang Y, Liu R. et al. Long-term effects of intense pulsed light combined with meibomian gland expression in the treatment of Meibomian gland dysfunction. Photomed Laser Surg. 2018;36:562–567. doi:10.1089/pho.2018.4499.
  • Bron AJ, de Paiva CS, Chauhan SK. et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438–510. doi:10.1016/j.jtos.2017.05.011.
  • Wang MTM, Vidal-Rohr M, Muntz A. et al. Systemic risk factors of dry eye disease subtypes: a New Zealand cross-sectional study. Ocul Surf. 2020;18:374–380. doi:10.1016/j.jtos.2020.04.003.
  • Xue AL, Wang MTM, Ormonde SE, Craig JP. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf. 2020;18:286–297. doi:10.1016/j.jtos.2020.01.003.
  • Schaumberg DA, Uchino M, Christen WG, Semba RD, Buring JE, Li JZ. Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction. PLoS One. 2013;8:e76121. doi:10.1371/journal.pone.0076121.
  • Peck T, Olsakovsky L, Aggarwal S. Dry eye syndrome in menopause and perimenopausal age group. J Midlife Health. 2017;8:51–54. doi:10.4103/jmh.JMH_41_17.
  • Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817–827. doi:10.2147/OPTH.S130706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.